NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.46
+1.18 (3.44%)
At close: Feb 27, 2026, 4:00 PM EST
35.28
-0.18 (-0.51%)
After-hours: Feb 27, 2026, 7:33 PM EST
NAMS Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for NAMS stock have an average target of 47.33, with a low estimate of 37 and a high estimate of 52. The average target predicts an increase of 33.47% from the current stock price of 35.46.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NAMS stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 4 | 5 |
| Buy | 5 | 4 | 4 | 4 | 4 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $41 → $45 | Strong Buy | Maintains | $41 → $45 | +26.90% | Feb 19, 2026 |
| Needham | Needham | Strong Buy Maintains $46 → $48 | Strong Buy | Maintains | $46 → $48 | +35.36% | Feb 18, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $44 → $47 | Buy | Maintains | $44 → $47 | +32.54% | Jan 21, 2026 |
| Stifel | Stifel | Strong Buy Maintains $44 → $50 | Strong Buy | Maintains | $44 → $50 | +41.00% | Dec 16, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $30 → $37 | Hold | Maintains | $30 → $37 | +4.34% | Dec 2, 2025 |
Financial Forecast
Revenue This Year
31.09M
from 22.50M
Increased by 38.17%
Revenue Next Year
209.45M
from 31.09M
Increased by 573.62%
EPS This Year
-1.75
from -1.72
EPS Next Year
-1.25
from -1.75
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 81.9M | 649.5M | |||
| Avg | 31.1M | 209.5M | |||
| Low | n/a | 22.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 264.0% | 1,989.0% | |||
| Avg | 38.2% | 573.6% | |||
| Low | - | -26.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.30 | 2.43 | |||
| Avg | -1.75 | -1.25 | |||
| Low | -2.36 | -2.85 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.